Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare June 15, 2026
Splash Beverage Group Announces Its Initial Closing on the First Tranche of Private Placement August 22, 2024
Splash Beverage Group Secures Statewide Authorization for SALT Naturally Flavored Tequila in Pennsylvania July 18, 2024
Splash Beverage Group Appoints Dr. John Paglia, a Professor of Finance at Pepperdine Graziadio Business School, to Its Board of Directors March 1, 2024